{"data":{"id":"us/21-cfr-250.103-250.104","jurisdiction":"us","citation":"21 CFR 250.103-250.104","heading":"§§ 250.103-250.104 [Reserved]","body":"","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER C—DRUGS: GENERAL","PART 250—SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS","Subpart B—New Drug or Prescription Status of Specific Drugs"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-250.102","next":"us/21-cfr-250.105"},"notice":"GroundRules: Original legal text. Not legal advice."}